Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Osteoarthritis Gene Therapy Market, by Region, 2019-2027 (USD Billion)
1.2.2. Osteoarthritis Gene Therapy Market, by Site of Injection, 2019-2027 (USD Billion)
1.2.3. Osteoarthritis Gene Therapy Market, by Vectors, 2019-2027 (USD Billion)
1.2.4. Osteoarthritis Gene Therapy Market, by End Use Industries, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Osteoarthritis Gene Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Osteoarthritis Gene Therapy Market Dynamics
3.1. Osteoarthritis Gene Therapy Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing Prevalence of Osteoarthritis
3.1.1.2. increasing geriatric population
3.1.2. Market Challenges
3.1.2.1. High Treatment Cost.
3.1.3. Market Opportunities
3.1.3.1. Rising technological advancements in gene therapy
3.1.3.2. Surging Healthcare Infrastructure in emerging economies.
Chapter 4. Global Osteoarthritis Gene Therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Osteoarthritis Gene Therapy Market, by Site of Injection
6.1. Market Snapshot
6.2. Global Osteoarthritis Gene Therapy Market by Site of Injection, Performance - Potential Analysis
6.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by Site of Injection 2018-2027 (USD Billion)
6.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis
6.4.1. Synovium
6.4.2. Cartilage
Chapter 7. Global Osteoarthritis Gene Therapy Market, by Vectors
7.1. Market Snapshot
7.2. Global Osteoarthritis Gene Therapy Market by Vectors, Performance - Potential Analysis
7.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by Vectors 2018-2027 (USD Billion)
7.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis
7.4.1. Non-viral
7.4.2. Retrovirus
7.4.3. Lentivirus
7.4.4. Adenovirus
7.4.5. Adeno-associated virus (AAV)
7.4.6. HSV
Chapter 8. Global Osteoarthritis Gene Therapy Market, by End Use Industries
8.1. Market Snapshot
8.2. Global Osteoarthritis Gene Therapy Market by End Use Industries, Performance - Potential Analysis
8.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by End Use Industries 2018-2027 (USD Billion)
8.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis
8.4.1. Hospitals and clinics
8.4.2. Orthopedic Centers
8.4.3. Assisted living Facilities
8.4.4. Nursing Homes
8.4.5. Ambulatory Surgical Centers
8.4.6. Others
Chapter 9. Global Osteoarthritis Gene Therapy Market, Regional Analysis
9.1. Osteoarthritis Gene Therapy Market, Regional Market Snapshot
9.2. North America Osteoarthritis Gene Therapy Market
9.2.1. U.S. Osteoarthritis Gene Therapy Market
9.2.1.1. Site of Injection breakdown estimates & forecasts, 2018-2027
9.2.1.2. Vectors breakdown estimates & forecasts, 2018-2027
9.2.1.3. End Use Industries breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Osteoarthritis Gene Therapy Market
9.3. Europe Osteoarthritis Gene Therapy Market Snapshot
9.3.1. U.K. Osteoarthritis Gene Therapy Market
9.3.2. Germany Osteoarthritis Gene Therapy Market
9.3.3. France Osteoarthritis Gene Therapy Market
9.3.4. Spain Osteoarthritis Gene Therapy Market
9.3.5. Italy Osteoarthritis Gene Therapy Market
9.3.6. Rest of Europe Osteoarthritis Gene Therapy Market
9.4. Asia-Pacific Osteoarthritis Gene Therapy Market Snapshot
9.4.1. China Osteoarthritis Gene Therapy Market
9.4.2. India Osteoarthritis Gene Therapy Market
9.4.3. Japan Osteoarthritis Gene Therapy Market
9.4.4. Australia Osteoarthritis Gene Therapy Market
9.4.5. South Korea Osteoarthritis Gene Therapy Market
9.4.6. Rest of Asia Pacific Osteoarthritis Gene Therapy Market
9.5. Latin America Osteoarthritis Gene Therapy Market Snapshot
9.5.1. Brazil Osteoarthritis Gene Therapy Market
9.5.2. Mexico Osteoarthritis Gene Therapy Market
9.6. Rest of The World Osteoarthritis Gene Therapy Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Flexion
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. GeneQuine
10.2.3. Novartis
10.2.4. Smith & Nephew
10.2.5. Genascence
10.2.6. Kolon TissueGene
10.2.7. Sanofi
10.2.8. Paraxel
10.2.9. Medipost co ltd
10.2.10. Mundipharma
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption